Item 5.02.  Departure of Directors or Principal Officers; Election of Directors;
Appointment of Principal Officers
On January 27, 2021, the Board of Directors (the "Board") of Ellington Financial
Inc. (the "Company") increased the size of the Board to six directors and
appointed Stephen J. Dannhauser to serve on the Board, effective January 27,
2021. Mr. Dannhauser will serve as a member of the Board until the Company's
next annual meeting of stockholders or until a successor is elected and
qualified. The Board also appointed Mr. Dannhauser as a member of the Audit
Committee, the Compensation Committee, and the Nominating and Corporate
Governance Committee. There are no arrangements or understandings between Mr.
Dannhauser and any other persons pursuant to which he was elected to serve on
the Board
Mr. Dannhauser and the Company will enter into the Company's standard
indemnification agreement substantially in the form previously filed with the
Securities and Exchange Commission providing for indemnification and advancement
of expenses. In addition, Mr. Dannhauser will be compensated for his service on
the Board in accordance with the Company's standard compensation policy for
non-employee directors.

Item 7.01. Regulation FD Disclosure On January 28, 2021, the Company issued a press release relating to the appointment of Dr. Ronald I. Simon as Chairman of the Board of the Company and the appointment of Mr. Dannhauser as a director of the Company, in each case effective January 27, 2021. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated into this Item 7.01 by reference.

Item 9.01. Financial Statements and Exhibits

(d) Exhibits. The following exhibit is being filed herewith this Current Report on Form 8-K.



99.1      Press release dated January 28, 2021
104  Cover Page Interactive Data File (embedded within the Inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses